STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma
about
Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: a Gynecologic Oncology Group study.The transcriptional responsiveness of LKB1 to STAT-mediated signaling is differentially modulated by prolactin in human breast cancer cells.A comprehensive evaluation of biomarkers predictive of response to PI3K inhibitors and of resistance mechanisms in head and neck squamous cell carcinoma.Complexity in the signaling network: insights from the use of targeted inhibitors in cancer therapy.Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancersDasatinib induces DNA damage and activates DNA repair pathways leading to senescence in non-small cell lung cancer cell lines with kinase-inactivating BRAF mutationsLeukemia-associated activating mutation of Flt3 expands dendritic cells and alters T cell responses.Dasatinib Inhibits DNA Repair after Radiotherapy Specifically in pSFK-Expressing Tumor Areas in Head and Neck Xenograft Tumors.Tumor grafts derived from patients with head and neck squamous carcinoma authentically maintain the molecular and histologic characteristics of human cancers.Reversal of chemosensitivity and induction of cell malignancy of a non-malignant prostate cancer cell line upon extracellular vesicle exposure.SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.JAK2 inhibition for the treatment of hematologic and solid malignancies.STAT3 signaling in pulmonary arterial hypertension.Differential gene expression of the key signalling pathway in para-carcinoma, carcinoma and relapse human pancreatic cancer.Mutations of the LIM protein AJUBA mediate sensitivity of head and neck squamous cell carcinoma to treatment with cell-cycle inhibitors.Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.Resistance of Cancer Cells to Targeted Therapies Through the Activation of Compensating Signaling Loops.miR-500a-3p promotes cancer stem cells properties via STAT3 pathway in human hepatocellular carcinomaPotential anti-cancer effect of curcumin in human lung squamous cell carcinoma.Expression of SOCSs in human prostate cancer and their association in prognosis.SOCS2 overexpression alleviates diabetic nephropathy in rats by inhibiting the TLR4/NF-κB pathway.Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.Turn down genes for WAT? Activation of anti-apoptosis pathways protects white adipose tissue in metabolically depressed thirteen-lined ground squirrels.
P2860
Q30416923-F52FA739-B535-41A4-A9FF-77DC03BD0C96Q33783277-0155BBD6-FA69-4C01-A193-A647BAA6F2A5Q34458117-1B11225E-0258-4F88-B498-5D0B695D3710Q35882137-44976681-E5B9-4D54-A05C-9C433E5B11A5Q35889525-4B82043F-38DC-4979-A7F7-03AFF2742AE7Q36729471-7A2F4FB1-D786-4FFF-A2E7-EE3E4FD0FC66Q36745048-6E08C662-DB88-484E-8C63-34AD2CFC6D22Q37060946-C31F49C3-4052-4BC9-87D2-DF3D18B5260FQ37351789-4B779D99-721E-4153-857C-C121F4EFB2A3Q37365585-562A8670-3A1B-4C49-B89C-C3C4958A54C7Q37533348-12F4BF5D-03A1-49AA-8EC4-BD3119CF8C46Q38001733-703F8ED5-4457-4919-8F2B-695320D7E6D4Q38140894-20055A65-3487-43F3-91C1-EF0373741E60Q38484647-5FFC0AF9-22FE-49DF-BB70-A7C16A29C4B7Q38719309-D5C33543-0316-49E4-96D6-96CB77A1463BQ39172495-B975E719-0D16-43DD-A027-207225E3F6E5Q39203633-D85B0A73-8416-4AA2-A900-1077A8282F10Q41163315-B1E7BD18-C9AB-414A-ADCA-0DE0A14504A8Q42282831-553F0560-5DC3-4367-8B41-86F6B33035B7Q46742441-9D1E02D3-14C2-4F3B-9AC6-685659DBE047Q47141766-34F8B754-E51B-470A-8DE4-92D87ABDAE73Q52646119-27D5D5A4-DE6B-4DC5-AFC2-8328FF54A058Q53132855-7267FA8D-E417-4ED6-A6D7-C7039EFB6154
P2860
STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@ast
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@en
type
label
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@ast
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@en
prefLabel
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@ast
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@en
P2093
P2860
P1476
STAT5A-mediated SOCS2 expressi ...... ad and neck squamous carcinoma
@en
P2093
Adel K El-Naggar
Banibrata Sen
Denise M Woods
Diana Bell
Faye M Johnson
Shaohua Peng
Stephen Y Lai
P2860
P304
P356
10.1158/1078-0432.CCR-11-1889
P407
P577
2011-11-16T00:00:00Z